Jazz Pharmaceuticals

VYXEOS - Cost

Last Updated: April 1st, 2024

HCPCS:

J9153

HCPCS Code Descriptor:

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

Medicare Payment Limit:

The VYXEOS Medicare Payment Limit is $232.803

Average Sale Price:

VYXEOS ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The VYXEOS Medicare Co-insurance percentage is 20%. VYXEOS's Medicare Co-insurance amount is $46.56 per HCPCS unit.

APC Code:

The Vyxeos APC Code is: 9302

APC Payment Limit:

The APC Payment Limit for VYXEOS is available. Login to view.

Vyxeos Cost Information:

VYXEOS, a product of Jazz Pharmaceuticals, became effective on January 1, 2019, and is associated with HCPCS J9153. There are three NDCs aligned to J Code: J9153. Prices generally increased by a few percentage points annually between 2019 and 2022. However, at the beginning of 2023, both WAC and AWP had several price swings. As of 2024, both have decreased by over 10%.

ACCESS PRICING AND MORE BY REGISTERING

Vyxeos’s wholesale acquisition cost (WAC) information was last updated on:
January 12, 2024
Vyxeos’s average wholesale price (AWP) information was last updated on:
January 12, 2024

Vyxeos Cost Graph: